← Ireland

S.I. No. 119/2024 - Infectious Diseases (Amendment) Regulations 2024

S.I. No. 119/2024 - Infectious Diseases (Amendment) Regulations 2024 Skip to content Disclaimer Feedback Helpdesk Gaeilge Léim go dtí an t-ábhar Séanadh Aiseolas Deasc chabhrach English Gaeilge English Produced by the Office of the Attorney General Táirgthe ag Oifig an Ard-Aighne Home Legislation Acts of the Oireachtas Statutory Instruments Pre-1922 Legislation Constitution External Resources Bills (Houses of the Oireachtas) Iris Oifigiúil / Official Gazette Revised Acts (LRC) Classified List of Legislation (LRC) Translations (acts.

  1. ie)Translations (Houses of the Oireachtas) Government Publications for Sale EU Law (EUR-Lex) FAQ Disclaimer Feedback Helpdesk Search Baile Reachtaíocht Achtanna an Oireachtais Ionstraimí Reachtúla Reachtaíocht Réamh-1922 Bunreacht Acmhainní Seachtracha Billí (Tithe an Oireachtais) Iris Oifigiúil Achtanna Athbhreithnithe (CAD) (An Coimisiún um Athchóiriú an Dlí) Liosta Rangaithe Reachtaíochta Aistriúcháin (achtanna.
  2. ie)Aistriúcháin (Tithe an Oireachtais) Foilseacháin Rialtais ar Díol Dlí AE (EUR-Lex) CCanna (Ceisteanna Coitianta) Séanadh Aiseolas Deasc chabhrach Cuardach TitleTeideal Year(
  3. s)or rangeBliain nó blianta nó raon TypeCineál All Legislation Acts Statutory Instruments Advanced SearchCuardach Casta HomeBaile Statutory InstrumentsIonstraimí Reachtúla 2024 S.I. No. 119/2024 - Infectious Diseases (Amendment) Regulations 2024 S.I. No. 119/2024 - Infectious Diseases (Amendment) Regulations 2024 AmendmentsLeasuithe Download PDF Íoslódáil PDF Notice of the making of this Statutory Instrument was published in “Iris Oifigiúil” of 29th March, 2024. I, STEPHEN DONNELLY, Minister for Health, in exercise of the powers conferred on me by sections 5 , 29 and 31 of the Health Act 1947 (No. 28 of 1947), hereby make the following regulations: 1.

(1)These Regulations may be cited as the Infectious Diseases (Amendment) Regulations 2024.
(2)“The Infectious Diseases Regulations 1981 to 2023” and these Regulations may be cited together as the Infectious Diseases Regulations 1981 to
  2. In these Regulations— “Principal Regulations” means the Infectious Diseases Regulations 1981 ( S.I. No. 390 of 1981 ); “Regulations (No. 3) of 2003” means the Infectious Diseases (Amendment) (No. 3) Regulations 2003 ( S.I. No. 707 of 2003 ); “Regulations of 2022” means the Infectious Diseases (Amendment) Regulations 2022 ( S.I. No. 258 of 2022 ); “Regulations of 2023” means the Infectious Diseases (Amendment) Regulations 2023 ( S.I. No. 245 of 2023 ).
  3. The Principal Regulations are amended by substituting for Regulation 8 (as last amended by Regulation 3 of the Regulations of 2022) the following: “All the infectious diseases listed in the Schedule to these Regulations except acute anterior poliomyelitis, cholera, diphtheria, influenza where it is influenza of a new or re-emergent subtype, mpox, paratyphoid, plague, severe acute respiratory syndrome (SARS), smallpox, tuberculosis, typhoid, typhus and viral haemorrhagic fevers (Lassa, Marburg, Ebola, Crimean-Congo) shall be excluded from the application of Section 38 of the Health Act 1947 as amended by Section 35 of the Health Act 1953.”
  4. Regulation 14
(1)(inserted by Regulation 4
(6)(
  1. i)of the Regulations (No. 3) of 2003) is amended by substituting for subparagraph (b), the following: “(
  2. b)further in the case of acute anterior poliomyelitis, anthrax, botulism, cholera, Covid-19 where it is Covid-19 of a new or re-emergent variant, diphtheria, enterohaemorrhagic escherichia coli, haemophilus influenzae disease, influenza where it is influenza of a new or re-emergent subtype, legionellosis, measles, meningococcal disease, mpox, paratyphoid, plague, rabies, severe acute respiratory syndrome (SARS), smallpox, tularemia, typhoid, typhus, viral haemorrhagic fevers (Lassa, Marburg, Ebola, Crimean-Congo), or yellow fever or where he or she is of the opinion that there is a serious outbreak of infectious disease in a locality, give immediate preliminary notification thereof to a medical officer of health.” 5. Regulation 15
(2)(inserted by Regulation 4
(7)of the Regulations (No. 3) of 2003) of the Principal Regulations is amended by substituting for paragraph 2(a), the following: “
(2)(a) Where a medical practitioner who is a medical officer of an infectious disease hospital or infectious disease unit is required under sub-regulation
(1)of this regulation to notify a case of acute anterior poliomyelitis, anthrax, botulism, cholera, Covid-19 where it is Covid-19 of a new or re-emergent variant, diphtheria, enterohaemorrhagic escherichia coli, haemophilus influenzae disease, influenza where it is influenza of a new or re-emergent subtype, legionellosis, measles, meningococcal disease, mpox, paratyphoid, plague, rabies, severe acute respiratory syndrome (SARS), smallpox, tularemia, typhoid, typhus, viral haemorrhagic fevers (Lassa, Marburg, Ebola, Crimean-Congo) or yellow fever, or where he or she is of the opinion that there is a serious outbreak of infectious disease in a locality he or she shall give immediate preliminary notification thereof to a medical officer of health.”
  1. The Principal Regulations are amended by substituting for the Schedule (inserted by Regulation 6 of the Regulations of 2022) the following: “Schedule Diseases specified to be infectious diseases and their respective causative pathogens Disease Causative Pathogen Acute anterior poliomyelitis Polio virus Ano-genital warts Human papilloma virus Anthrax Bacillus anthracis Bacillus cereus food-borne infection/intoxication Bacillus cereus Bacterial meningitis (not otherwise specified) Botulism Clostridium botulinum Brucellosis Brucella species Campylobacter infection Campylobacter species Carbapenemase producing enterobacteriaceae, infection or colonisation Enterobacteriaceae Chancroid Haemophilus ducreyi Chickenpox - hospitalised cases Varicella-zoster virus Chikungunya disease Chikungunya virus Chlamydia trachomatis infection (genital) Chlamydia trachomatis Cholera Vibrio cholerae Clostridium difficile infection Clostridium difficile Clostridium perfringens (type A) food- borne disease Clostridium perfringens Covid-19 SARS-CoV-2 Creutzfeldt Jakob disease variant Creutzfeldt Jakob disease Cryptosporidiosis Cryptosporidium parvum, hominis Cytomegalovirus infection (congenital) Cytomegalovirus Dengue Fever Dengue Virus Diphtheria Corynebacterium diphtheriae or ulcerans (toxin producing) Echinococcosis Echinococcus species Enterococcal bacteraemia Enterococcus species (blood) Escherichia coli infection (invasive) Escherichia coli (blood, CSF) Giardiasis Giardia lamblia Gonorrhoea Neisseria gonorrhoeae Granuloma inguinale Klebsiella granulomatis Haemophilus influenzae disease (invasive) Haemophilus influenzae (blood, CSF or other normally sterile site) Hepatitis A (acute) infection Hepatitis A virus Hepatitis B (acute and chronic) infection Hepatitis B virus Hepatitis C infection Hepatitis C virus Hepatitis E Infection Hepatitis E virus Herpes simplex (genital) Herpes simplex virus Herpes simplex (neonatal) Herpes simplex virus Human immunodeficiency virus infection Human immunodeficiency virus Influenza Influenza A and B virus Klebsiella pneumoniae infection (invasive) Klebsiella pneumoniae (blood or CSF) Legionellosis Legionella species Leprosy Mycobacterium leprae Leptospirosis Leptospira species Listeriosis Listeria monocytogenes Lyme disease (neuroborreliosis) Borrelia burgdorferi Lymphogranuloma venereum Chlamydia trachomatis Malaria Plasmodium falciparum, vivax, knowlesi, ovale, malariae mcr-positive Enterobacteriaceae Enterobacteriaceae infection or colonisation Measles Measles virus Meningococcal disease Neisseria meningitidis Mpox Monkeypox virus of the Orthopoxvirus genus Mumps Mumps virus Non-specific urethritis Novel or Rare Antimicrobial-resistant Organism (NRAO) Noroviral infection Norovirus Paratyphoid Salmonella Paratyphi Pertussis Bordetella pertussis Plague Yersinia pestis Pseudomonas aeruginosa infection (invasive) Pseudomonas aeruginosa (blood or CSF) Q Fever Coxiella burnetii Rabies Rabies virus Respiratory syncytial virus infection Respiratory syncytial virus Rotavirus infection Rotavirus Rubella Rubella virus Salmonellosis Salmonella spp other than S. Typhi and S. Paratyphi Severe Acute Respiratory Syndrome (SARS) SARS-associated coronavirus Shigellosis Shigella species Smallpox Variola virus Staphylococcal food poisoning Enterotoxigenic Staphylococcus aureus Staphylococcus aureus bacteraemia Staphylococcus aureus (blood) Streptococcus group A infection (invasive) Streptococcus pyogenes (blood, CSF or other normally sterile site) Streptococcus group B infection (invasive) Streptococcus agalactiae (blood, CSF, or other normally sterile site) Streptococcus pneumoniae infection (invasive) Streptococcus pneumoniae (blood, CSF or other normally sterile site) Syphilis Treponema pallidum Tetanus Clostridium tetani Toxoplasmosis Toxoplasma gondii Trichinosis Trichinella species Trichomoniasis Trichomonas vaginalis Tuberculosis Mycobacterium tuberculosis complex Tularemia Francisella tularensis Typhoid Salmonella Typhi Typhus Rickettsia prowazekii Verotoxigenic Escherichia coli infection Verotoxin producing Escherichia coli Viral encephalitis Viral haemorrhagic fevers Viral meningitis West Nile fever West Nile virus Yellow fever Yellow fever virus Yersiniosis Yersinia enterocolitica, Yersinia pseudotuberculosis Zika virus infection Zika virus”. GIVEN under my Official Seal, 25 March,
  2. STEPHEN DONNELLY, Minister for Health. EXPLANATORY NOTE (This note is not part of the Instrument and does not purport to be a legal interpretation.) The Infectious Diseases Regulations 1981 ( S.I. No. 390 of 1981 ) (“the Principal Regulations”) include “Human monkeypox infection” amongst the list of diseases designated as an “infectious disease” for the purposes of the Health Act
  3. These Regulations update the nomenclature on “Human monkeypox infection” to “mpox” in line with World Health Organisation guidance. These Regulations also amend the Principal Regulations to remove COVID-19 from the list of diseases requiring preliminary notification (i.e. immediate notification by telephone) except in cases of new or re-emergent variants of the disease. In addition, these Regulations amend the Principal Regulations to remove COVID-19 from the list of infectious diseases that a person (who is a probable source of infection with the disease) may (as a necessary safeguard against the spread of the disease) be detained and isolated for, in accordance with the Health Act
  4. Privacy Statement Accessibility European Legislation Identifier (PDF) Open Data License Ráiteas Príobháideachais Inrochtaineacht Aitheantóir Eorpach Reachtaíochta (ELI) Ceadúnas Sonraí Oscailte Liosta Fianán © Government of Ireland. Oireachtas Copyright Material is reproduced with the permission of the Houses of the Oireachtas © Rialtas na hÉireann. Atáirgtear ábhar faoi Chóipcheart le cead ó Thithe an Oireachtais

🔗 To official source

AI explanation based on the official legal text. Indicative, not a substitute for legal advice.